Umberger Traci S sold $901K of KMTS
Umberger Traci S (See Remarks) sold 30,000 shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) at $30.03 ($0.90M total) on 2026-10-27 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure confirms an open-market sale of 30,000 shares at $30.0294 per share on 2026-10-27, with holdings after the transaction of 195,825 shares, under a pre-arranged 10b5-1 plan.
Market read
Traders may monitor insider activity for sentiment, but a 10b5-1 sale is generally not a strong standalone catalyst.
What to watch
The filing does not indicate whether other insiders sold/bought around the same time, nor does it provide context on total insider ownership changes beyond the post-transaction share count.
Background
This is an SEC Form 4 insider transaction disclosure for Kestera Medical Technologies, Ltd. (KMTS), reported by officer/director Traci S Umberger.
Ticker impact
Insider Traci S Umberger sold 30,000 shares of KMTS for about $900,882 under a pre-arranged 10b5-1 plan filed with the SEC Form 4.
Likely neutral to slightly negative near-term as traders may briefly price in insider selling, though 10b5-1 structure reduces interpretability.
The article provides only the sale details and explicitly notes a pre-arranged 10b5-1 plan, which usually dampens inference about company fundamentals.
Market effects
No clear sector read-through from a single routine insider sale.
None.
None.
Counterpoint
Because the sale is explicitly under a 10b5-1 plan, the market may overreact; price impact could be negligible once traders recognize it as pre-scheduled.
Key entities
- issuerKMTS
Kestera Medical Technologies, Ltd., the company whose insider sale is disclosed.
- insiderTraci S Umberger
Officer and director who sold shares under a 10b5-1 plan.



